Arcturus Therapeutics Ltd (ARCT)
9.98 +0.55 (+5.83%) 11:08 ET [NASDAQ]
9.91 x 100 9.98 x 80
Realtime by (Cboe BZX)
9.91 x 100 9.98 x 80
Realtime 8.93 -0.50 (-5.30%) 09:23 ET
for Wed, Apr 2nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 292,028 | 347,005 | 391,883 | 370,492 | 462,895 |
Receivables | 3,974 | 32,064 | 2,764 | 3,367 | 2,125 |
TOTAL | $305,979 | $386,590 | $403,333 | $378,961 | $467,789 |
Non-Current Assets | |||||
PPE Net | 9,531 | 12,427 | 12,415 | 5,643 | 3,378 |
Investments And Advances | 0 | 0 | 0 | 515 | 0 |
Other Non-Current Assets | 28,559 | 30,385 | 34,639 | 7,695 | 5,289 |
TOTAL | $38,090 | $42,812 | $47,054 | $13,853 | $8,667 |
Total Assets | $344,069 | $429,402 | $450,387 | $392,814 | $476,456 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | 60,655 | 22,474 | 1,250 |
Accounts payable and accrued liabilities | 7,194 | 5,279 | 7,449 | 10,058 | 10,774 |
Accrued Expenses | 38,781 | 31,881 | 30,232 | 23,523 | 19,389 |
TOTAL | $65,489 | $81,989 | $126,984 | $99,537 | $49,521 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | N/A | N/A | 40,633 | 13,845 |
Deferred Revenues | 19,514 | 44,829 | 28,648 | 43,482 | 18,108 |
aiOther Non-Current Liabilities | 24,998 | 26,404 | 33,020 | 4,502 | 4,025 |
TOTAL | $37,602 | $68,900 | $53,091 | $65,066 | $30,382 |
Total Liabilities | $103,091 | $150,889 | $180,075 | $164,603 | $79,903 |
Shareholders' Equity | |||||
Shares Outstanding, K | 27,120 | 26,915 | 26,555 | N/A | N/A |
Common Shares | 27 | 27 | 27 | 26 | 26 |
Retained earnings | -448,807 | -367,866 | -338,141 | -347,490 | -143,816 |
TOTAL | $240,978 | $278,513 | $270,312 | $228,211 | $396,553 |
Total Liabilities And Equity | $344,069 | $429,402 | $450,387 | $392,814 | $476,456 |